{"DataElement":{"publicId":"3139227","version":"1","preferredName":"FLT Positron Emission Tomography Uptake Category","preferredDefinition":"Text classification to signify the extent of uptake of 3\"-deoxy-3\"-[18F]fluorothymidine (18F-FLT) during a positron emission tomography (PET) assessment.","longName":"FLT_PET_UPT_CAT","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3139220","version":"1","preferredName":"3'-deoxy-3'-[18F]fluorothymidine Positron Emission Tomography Standard Uptake Value","preferredDefinition":"A radioconjugate consisting of a thymidine analogue radiolabeled with fluorine F 18, a positron emitting isotope.  Phosphorylated by S-phase-specific thymidine kinase 1, 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) is trapped intracellularly by entering the salvage pathway of DNA synthesis without incorporation into DNA. 18F-FLT serves a marker of tumor cell proliferation for imaging with positron emission tomography (PET); as a marker of proliferation rather than metabolism, it is more specific to tumor tissue than 2-deoxy-2-[18F] fluoro-D-glucose (18F-FDG).  This agent is metabolically stable, accumulates in the normal bone marrow and the liver, and does not cross the blood-brain barrier._A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered._Regularly and widely used._The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention._A numerical quantity measured or assigned or computed.","longName":"FLT_PET_SUV","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2983312","version":"1","preferredName":"3'-deoxy-3'-[18F]fluorothymidine Positron Emission Tomography","preferredDefinition":"A radioconjugate consisting of a thymidine analogue radiolabeled with fluorine F 18, a positron emitting isotope.  Phosphorylated by S-phase-specific thymidine kinase 1, 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) is trapped intracellularly by entering the salvage pathway of DNA synthesis without incorporation into DNA. 18F-FLT serves a marker of tumor cell proliferation for imaging with positron emission tomography (PET); as a marker of proliferation rather than metabolism, it is more specific to tumor tissue than 2-deoxy-2-[18F] fluoro-D-glucose (18F-FDG).  This agent is metabolically stable, accumulates in the normal bone marrow and the liver, and does not cross the blood-brain barrier.:A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","longName":"C49093:C17007","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorothymidine F-18","conceptCode":"C49093","definition":"A radioconjugate consisting of a thymidine analogue radiolabeled with fluorine F 18, a positron emitting isotope.  Phosphorylated by S-phase-specific thymidine kinase 1, 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) is trapped intracellularly by entering the salvage pathway of DNA synthesis without incorporation into DNA. 18F-FLT serves a marker of tumor cell proliferation for imaging with positron emission tomography (PET); as a marker of proliferation rather than metabolism, it is more specific to tumor tissue than 2-deoxy-2-[18F] fluoro-D-glucose (18F-FDG).  This agent is metabolically stable, accumulates in the normal bone marrow and the liver, and does not cross the blood-brain barrier.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CA08D38-A85C-FF40-E040-BB89AD431598","latestVersionIndicator":"Yes","beginDate":"2010-01-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-07","modifiedBy":"ONEDATA","dateModified":"2010-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3139218","version":"1","preferredName":"Standard Uptake Value","preferredDefinition":"Regularly and widely used.:The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.:A numerical quantity measured or assigned or computed.","longName":"C44275:C71688:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Standard","conceptCode":"C44275","definition":"Regularly and widely used.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"907B608E-1AAA-7DCE-E040-BB89AD435148","latestVersionIndicator":"Yes","beginDate":"2010-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-17","modifiedBy":"ONEDATA","dateModified":"2010-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"907B608E-1ABB-7DCE-E040-BB89AD435148","latestVersionIndicator":"Yes","beginDate":"2010-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3139222","version":"1","preferredName":"3'-deoxy-3'-[18F]fluorothymidine Uptake Category","preferredDefinition":"A radioconjugate consisting of a thymidine analogue radiolabeled with fluorine F 18, a positron emitting isotope.  Phosphorylated by S-phase-specific thymidine kinase 1, 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) is trapped intracellularly by entering the salvage pathway of DNA synthesis without incorporation into DNA. 18F-FLT serves a marker of tumor cell proliferation for imaging with positron emission tomography (PET); as a marker of proliferation rather than metabolism, it is more specific to tumor tissue than 2-deoxy-2-[18F] fluoro-D-glucose (18F-FDG).  This agent is metabolically stable, accumulates in the normal bone marrow and the liver, and does not cross the blood-brain barrier._The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention._Category; used informally to mean a class of things.","longName":"FLT_UPT_CAT","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"> Mediastinum","valueDescription":"Greater Than Mediastinum","ValueMeaning":{"publicId":"3139223","version":"1","preferredName":"Greater Than Mediastinum","longName":"3139223","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: (mee-dee-a-STYE-num) The area between the lungs. The organs in this area include the heart and its large blood vessels, the trachea, the esophagus, the bronchi, and lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mediastinum","conceptCode":"C12748","definition":"An anatomic site along the midline and under the sternum that contains the heart and pericardium, the bases of the great vessels, the trachea and bronchi, esophagus, thymus, lymph nodes, thoracic duct, phrenic and vagus nerves, and other structures and tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"907B608E-1B04-7DCE-E040-BB89AD435148","latestVersionIndicator":"Yes","beginDate":"2010-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"907B608E-1B1D-7DCE-E040-BB89AD435148","beginDate":"2010-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-17","modifiedBy":"ONEDATA","dateModified":"2010-09-17","deletedIndicator":"No"},{"value":"= Mediastinum","valueDescription":"Uptake To Mediastinum","ValueMeaning":{"publicId":"3139224","version":"1","preferredName":"Uptake To Mediastinum","longName":"3139224","preferredDefinition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.: Used as a function word to indicate direction, purpose, or movement.: (mee-dee-a-STYE-num) The area between the lungs. The organs in this area include the heart and its large blood vessels, the trachea, the esophagus, the bronchi, and lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mediastinum","conceptCode":"C12748","definition":"An anatomic site along the midline and under the sternum that contains the heart and pericardium, the bases of the great vessels, the trachea and bronchi, esophagus, thymus, lymph nodes, thoracic duct, phrenic and vagus nerves, and other structures and tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"907B608E-1B2B-7DCE-E040-BB89AD435148","latestVersionIndicator":"Yes","beginDate":"2010-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"907B608E-1B44-7DCE-E040-BB89AD435148","beginDate":"2010-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-17","modifiedBy":"ONEDATA","dateModified":"2010-09-17","deletedIndicator":"No"},{"value":"< Mediastinum","valueDescription":"Less Than Mediastinum","ValueMeaning":{"publicId":"3139225","version":"1","preferredName":"Less Than Mediastinum","longName":"3139225","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.: (mee-dee-a-STYE-num) The area between the lungs. The organs in this area include the heart and its large blood vessels, the trachea, the esophagus, the bronchi, and lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than","conceptCode":"C61585","definition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mediastinum","conceptCode":"C12748","definition":"An anatomic site along the midline and under the sternum that contains the heart and pericardium, the bases of the great vessels, the trachea and bronchi, esophagus, thymus, lymph nodes, thoracic duct, phrenic and vagus nerves, and other structures and tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"907B608E-1B51-7DCE-E040-BB89AD435148","latestVersionIndicator":"Yes","beginDate":"2010-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"907B608E-1B6A-7DCE-E040-BB89AD435148","beginDate":"2010-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-17","modifiedBy":"ONEDATA","dateModified":"2010-09-17","deletedIndicator":"No"},{"value":"No uptake","valueDescription":"No Uptake","ValueMeaning":{"publicId":"3139226","version":"1","preferredName":"No Uptake","longName":"3139226","preferredDefinition":"The non-affirmative response to a question.: The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"907B608E-1B77-7DCE-E040-BB89AD435148","latestVersionIndicator":"Yes","beginDate":"2010-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"907B608E-1B90-7DCE-E040-BB89AD435148","beginDate":"2010-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-17","modifiedBy":"ONEDATA","dateModified":"2010-09-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3139221","version":"1","preferredName":"3'-deoxy-3'-[18F]fluorothymidine Uptake Category","preferredDefinition":"A radioconjugate consisting of a thymidine analogue radiolabeled with fluorine F 18, a positron emitting isotope.  Phosphorylated by S-phase-specific thymidine kinase 1, 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) is trapped intracellularly by entering the salvage pathway of DNA synthesis without incorporation into DNA. 18F-FLT serves a marker of tumor cell proliferation for imaging with positron emission tomography (PET); as a marker of proliferation rather than metabolism, it is more specific to tumor tissue than 2-deoxy-2-[18F] fluoro-D-glucose (18F-FDG).  This agent is metabolically stable, accumulates in the normal bone marrow and the liver, and does not cross the blood-brain barrier.:The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.:Category; used informally to mean a class of things.","longName":"C49093:C71688:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorothymidine F-18","conceptCode":"C49093","definition":"A radioconjugate consisting of a thymidine analogue radiolabeled with fluorine F 18, a positron emitting isotope.  Phosphorylated by S-phase-specific thymidine kinase 1, 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) is trapped intracellularly by entering the salvage pathway of DNA synthesis without incorporation into DNA. 18F-FLT serves a marker of tumor cell proliferation for imaging with positron emission tomography (PET); as a marker of proliferation rather than metabolism, it is more specific to tumor tissue than 2-deoxy-2-[18F] fluoro-D-glucose (18F-FDG).  This agent is metabolically stable, accumulates in the normal bone marrow and the liver, and does not cross the blood-brain barrier.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"907B608E-1ADD-7DCE-E040-BB89AD435148","latestVersionIndicator":"Yes","beginDate":"2010-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-17","modifiedBy":"ONEDATA","dateModified":"2010-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"907B608E-1AEE-7DCE-E040-BB89AD435148","latestVersionIndicator":"Yes","beginDate":"2010-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-17","modifiedBy":"ONEDATA","dateModified":"2010-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2879403","version":"1","longName":"Virginia Commonwealth University","context":"NCIP"},{"publicId":"2879404","version":"1","longName":"VCU New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"FLT Uptake Criteria","type":"Preferred Question Text","description":"FLT Uptake Criteria","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"907B608E-1B9A-7DCE-E040-BB89AD435148","latestVersionIndicator":"Yes","beginDate":"2010-09-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-17","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":"Curated to support Virginia Commonwealth University trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}